Zoetis Companion Animal — Revenue decreased by 5.1% to $1.52B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.7%, from $1.55B to $1.52B. Over 4 years (FY 2021 to FY 2025), Companion Animal — Revenue shows an upward trend with a 8.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong demand for pet health products, successful product launches, or increased market share in the companion animal sector, while a decrease may signal competitive pressure or a slowdown in pet ownership trends.
This metric represents the total gross sales generated from products and services specifically designed for companion an...
Peers in the animal health industry report similar segment-specific revenues, often categorized by species or therapeutic area, allowing for benchmarking against other major veterinary pharmaceutical providers.
zts_segment_companion_animal_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.23B | $1.20B | $1.18B | $1.26B | $1.37B | $1.27B | $1.30B | $1.23B | $1.49B | $1.41B | $1.45B | $1.45B | $1.65B | $1.61B | $1.57B | $1.55B | $1.79B | $1.65B | $1.60B | $1.52B |
| QoQ Change | — | -2.2% | -1.7% | +6.9% | +8.2% | -7.0% | +2.5% | -6.0% | +21.6% | -5.0% | +2.4% | +0.1% | +13.7% | -2.4% | -2.4% | -1.5% | +15.7% | -7.6% | -3.1% | -5.1% |
| YoY Change | — | — | — | — | +11.1% | +5.7% | +10.2% | -3.0% | +9.0% | +11.3% | +11.1% | +18.4% | +10.7% | +13.8% | +8.4% | +6.6% | +8.4% | +2.7% | +2.0% | -1.7% |